ATWLPPR Peptide TFA
ATWLPPR Peptide TFA, a heptapeptide, acts as a selective neuropilin-1 inhibitor, inhibits VEGF165 binding to NRP-1, used in the research of angiogenesis. ATWLPPR Peptide TFA has potential in reducing the early retinal damage caused by diabetes.
Product Specifications
Field of Research
Immunology & Inflammation
Purity
>98%
Smiles
O=C (N[C@@H] ([C@H] (O) C) C (N[C@@H] (CC1=CNC2=CC=CC=C12) C (N[C@@H] (CC (C) C) C (N3[C@@H] (CCC3) C (N4[C@@H] (CCC4) C (N[C@@H] (CCCNC (N) =N) C (O) =O) =O) =O) =O) =O) =O) [C@H] (C) N.OC (C (F) (F) F) =O
Molecular Formula
C42H62F3N11O11
Molecular Weight
954
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
GTR15331713 1 Vial
Lentiviral human ERGIC2 shRNA (UAS) - Lentiviral human ERGIC2 shRNA (UAS) (100)
Sign In for Pricing
View Details